Skip to Content
Merck
  • [How I treat...topical treatment of plaque type psoriasis by the combination of calcipotriol and betamethasone dipropionate].

[How I treat...topical treatment of plaque type psoriasis by the combination of calcipotriol and betamethasone dipropionate].

Revue medicale de Liege (2006-05-10)
F Henry, C Flagothier, C Piérard-Franchimont, G E Piérard
PMID16680996
ABSTRACT

The combination of calcipotriol and betamethasone dipropionate in a single topical formulation is a recent advance in treatment of plaque type psoriasis. Studies rooted on evidence-based medicine have been recently published. We report a synthesis and a critical analysis, critical analysis of these investigations, and translate their data with a view to apply them in daily practice.

MATERIALS
Product Number
Brand
Product Description
Y0001416
Betamethasone dipropionate for peak identification, European Pharmacopoeia (EP) Reference Standard
34166
Supelco
Betamethasone, VETRANAL®, analytical standard
B1152
Sigma-Aldrich
Betamethasone 17,21-dipropionate
B7005
Sigma-Aldrich
Betamethasone, ≥98%
1067704
USP
Betamethasone dipropionate, United States Pharmacopeia (USP) Reference Standard
B1040000
Betamethasone dipropionate, European Pharmacopoeia (EP) Reference Standard
B1000000
Betamethasone, European Pharmacopoeia (EP) Reference Standard
PHR1399
Supelco
Betamethasone Dipropionate, Pharmaceutical Secondary Standard; Certified Reference Material
PHR1398
Supelco
Betamethasone, Pharmaceutical Secondary Standard; Certified Reference Material